Open-access endoscopy: Are age-based guidelines justified? An audit of experience of 1000 open-access endoscopies at a district general hospital

Endoscopy

Volumn 35, Issue 1, 2003, Pages 68-73

  Boulton Jones, J R ^a   Follows, M C ^a   Mahmoud, A A ^a  

^a KING S MILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT;

AGE; ARTICLE; BARRETT ESOPHAGUS; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CONTROLLED STUDY; DEATH; DIGESTIVE SYSTEM CANCER; DUODENUM ULCER; ESOPHAGITIS; ESOPHAGUS CANCER; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GENERAL HOSPITAL; HELICOBACTER INFECTION; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; METASTASIS; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH ULCER; UPPER GASTROINTESTINAL TRACT;

ADULT; AGE FACTORS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL DISEASES; GUIDELINE ADHERENCE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MEDICAL AUDIT; MIDDLE AGED; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 0037241950     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-36407     Document Type: Article

References (33)

1. Jones R, Lydeard S. Dyspepsia in the community: A follow-up study. Br J Clin Pract 1992; 46: 95-97
2. Working Party of the Clinical Services Committee of the British Society of Gastroenterology. Provision of gastrointestinal endoscopy and related services for a district general hospital. Gut 1991; 32: 95-105
3. Asante MA, Mendall MA, Bland JM, Northfield TC. Determinants of prescribing costs for ulcer-healing drugs and upper gastrointestinal endoscopy in general practice. Eur J Gastroenterol Hepatol 1998; 10: 589-593
4. Silcock JG, Bramble MG. Open access endoscopy: Second survey of current practice in the United Kingdom. Gut 1997; 40: 192-195
5. Breslin NP, Thomson ABR, Bailey RJ et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 2000; 46: 93-97
6. Christie J, Shepard NA, Codling BW, Valori RM. Gastric cancer below the age of 55: Implications for screening patients with uncomplicated dyspepsia. Gut 1997; 41: 513-517
7. Patel P, Khulusi MA, Lloyd R et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315-1318
8. Vyas SK, Sharpstone D, Treasure J et al. Pre-endoscopy screening using serodiagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 783-785
9. British Society of Gastroenterology. Dyspepsia management guidelines. Guidelines in Gastroenterology. London: British Society of Gastroenterology, 1996
10. Talley NJ, Axon A, Bytzer P et al. Management of uninvestigated and functional dyspepsia: A working party report for the World Congress of Gastroenterology 1998. Aliment Pharmacol Ther 1998; 13: 1135-1148
11. Bytzer P, Hansen JM, Schaffalitzky De Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-816
12. Hungin APS, Thomas PR, Bramble MG et al. What happens to patients following open access endoscopy? An outcome study from general practice. Br J Gen Pract 1994; 44: 519-521
13. Gear MWL, Wilkinson SP. Open access alimentary endoscopy. Br J Hosp Med 1989; 41: 438-444
14. Bramble MG, Cooke WM, Corbett WA et al. Organising unrestricted open access in South Tees. Gut 1993; 34: 422-427
15. Bodger K, Eastwood PG, Mannings SI et al. Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Guidelines (1996). Aliment Pharmacol Ther 2000; 14: 413-420
16. Manes G, Balzano A, Marone P et al. Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy system: A prospective observational study based on the Maastricht guidelines. Aliment Pharmacol Ther 2002; 16: 105-110
17. Harvey RF, Spence RW, Lane AJ et al. Relationship between changing patterns of Helicobacter pylori-related duodenal ulcer over 20 years and H. pylori infection rates in the local community: The Bristol Helicobacter Project. Gastroenterology 2001; 120: A240
18. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378-1386
19. Thompson WG. Dyspepsia: Is a trial of therapy appropriate? Can Med Assoc J 1995; 153: 293-299
20. Hansen JM, Bytzer P, Bondesen S, Schaffalitzky De Muckadell OB. Efficacy and outcome of an open access endoscopy service. Dan Med Bull 1991; 38: 288-290
21. Johannessen T, Peterson H, Kleveland PM. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689-697
22. Moayyedi P, Zilles A, Clough M et al. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia. Eur J Gastroenterol Hepatol 1999; 11: 1245-1250
23. Bowie PE, Cox RA, Davidson AR, Steel A. Young dyspeptic patients: With a test-and-treat policy: Are the benefits of decreased symptom severity and oesophago-gastric-duodenoscopy workload sustained? Eur J Gastroenterol Hepatol 2001; 13: 541-545
24. Collins JSA, Bamford KB, Sloan JM et al. Screening for Helicobacter pylori antibody could reduce endoscopy workload in young dyspeptic patients. Eur J Gastroenterol Hepatol 1992; 4: 991-993
25. McColl KEL, Murray LS, Gillen D et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. BMJ 2002; 324: 999-1002
26. Delaney BC, Wilson S, Roalfe A et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: A randomised controlled trial in primary care. Lancet 2000; 356: 1965-1969
27. Delaney BC, Wilson S, Roalfe A et al. Randomised controlled trial of Helicobacter pylori testing and endoscopy in primary care. BMJ 2001; 322: 898-901
28. Sue-Ling HM, Johnstone D, Martin IG et al. Gastric cancer: A curable disease in Britain. BMJ 1993; 307: 591-596
29. Suvakovic Z, Bramble MG, Jones R et al. Improving the detection rate of early gastric cancer requires more than open access gastroscopy: A five year study. Gut 1997; 41: 308-313
30. Haugstvedt TK, Viste A, Eide GE, Soreide O. Patient and physician treatment delay in patients with stomach cancer in Norway: Is it important? The Norway Stomach Cancer Trial. Scand J Gastroenterol 1991; 26: 611-619
31. Martin IG, Young S, Sue-Ling H, Johnstone D. Delays in the diagnosis of oesophagogastric carcinoma: A consecutive case series. BMJ 1997; 314: 467-470
32. Kiesslich R, Hahn M, Herrmann G, Jung M. Screening for specialized columnar epithelium with methylene blue chromoendoscopy in patients with Barrett's oesophagus and a normal control group. Gastrointest Endosc 2001; 53: 47-52
33. Dave U, Shousha S, Westaby D. Methylene blue staining: Is it really useful in Barrett's oesophagus. Gastrointest Endosc 2001; 53: 333-335